Article
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Potentially hazardous eye care products recalled nationwide
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Q&A: Carl D. Regillo, MD, shares updates on the VERONA trial for DME
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Q&A: Dilsher S. Dhoot, MD, on the HELIOS trial for diabetic retinopathy
Belantamab mafodotin–induced corneal changes in patients with multiple myeloma